WNT-974

N/A

Report date: 2024/12/20 11:49:00
NME

Base Information

Drug NameWNT-974
Drug Alias NameLGK-974NVP-LGK974WNT-974
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein-serine O-palmitoleoyltransferase porcupine inhibitorsWnt signalling pathway inhibitors
TargetsProtein-serine O-palmitoleoyltransferase porcupine
Therapy Area/IndicationsPancreatic NeoplasmsColorectal NeoplasmsTriple Negative Breast Neoplasms +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesNetherlands +[7] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesNovartis Pharma Ag
Inactive CompaniesUniversity Of Michigan Rogel Cancer Center
Active IndicationsPancreatic NeoplasmsColorectal NeoplasmsTriple Negative Breast Neoplasms +[8] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A